Magnus Veritas Medical Technologies — MVMT — Regenerative and Orthobiologic Technologies
Clinical Resources

The evidence behind the catalog.

Supporting literature and clinical background for each technology category. Request the papers for any category below and we’ll send them over directly.

Bone Growth Stimulation

Evidence on fusion healing support

Peer-reviewed literature on electrical and electromagnetic stimulation as an adjunct to spinal and long-bone fusion healing. A Level I systematic review and meta-analysis of randomized controlled trials (n=941) found electrical stimulation increased the odds of successful fusion 2.5-fold relative to control (OR 2.53, 95% CI 1.86–3.43, p<0.00001), with no significant subgroup interaction by stimulation type (p=0.93) — the pooled benefit held across capacitive coupling as a modality. A randomized double-blind placebo-controlled trial of capacitively coupled stimulation across 28 U.S. surgical sites reported an 84.7% success rate in actively stimulated patients versus 64.9% in placebo (p=0.0043), with the greatest benefit in posterolateral fusion and when internal fixation was used. Mechanism work by Brighton and colleagues established that capacitively coupled signal transduction proceeds through voltage-gated calcium channels — blocked by verapamil but not by inositol-phosphate inhibitors — raising cytosolic calcium, activating calmodulin, and upregulating TGF-β1 and other osteopromotive factors.

Systematic review & meta-analysis, Scientific Reports (2020) — doi:10.1038/s41598-020-61266-x Goodwin et al., Spine (1999) — PMID 10404578 Massari et al., Int J Spine Surg (2020) — doi:10.14444/7142 Brighton et al., J Bone Joint Surg Am (2001) — signal transduction, PMID 11679602 Zhuang, Brighton et al., Biochem Biophys Res Commun (1997) — PMID 9268690 Request the literature →
Bone Marrow Aspiration

Evidence on autologous cell therapy

Published data on point-of-care bone marrow aspirate and its role in bone and soft-tissue healing, including work establishing CFU-f content — rather than total nucleated cell or platelet count — as the variable correlating with clinical outcomes in non-union and osteonecrosis, and the effect of aspiration volume and technique on graft cellularity.

Hernigou et al., International Orthopaedics (2013) — doi:10.1007/s00264-013-2017-z Request the literature →
Synthetic Osteoconductive Scaffold

Evidence on graft substitute performance

Clinical and pre-clinical data on synthetic scaffold materials as an alternative or adjunct to autograft/allograft. A 2025 peer-reviewed study evaluated a hyper-crosslinked carbohydrate polymer across an ovine spinal fusion model and 63 adult spinal fusion procedures, reporting a 91.8% overall fusion rate (100% thoracic, 95% lumbar, 85% cervical), visible osseous formation within three months, and no adverse events. Additional published work covers critical-size defect repair, foot and ankle limb salvage, ISO 10993 biocompatibility, and the embryonic bone-development biology the material was designed around.

Kim et al., Bioengineering (2025) — doi:10.3390/bioengineering12030243 Kim & Lee, Advances in Spine Surgery (2023) — doi:10.5772/intechopen.1002037 Request the full set →
PRP & Regenerative Injection

Evidence on platelet-rich therapies

Research on PRP, A2M, and related autologous injection therapies for joint and soft-tissue applications. A 2024 systematic review found higher platelet dose associated with better outcomes in knee osteoarthritis. A 2014 study identified alpha-2-macroglobulin as a master inhibitor of cartilage-degrading factors, attenuating post-traumatic OA progression.

Berrigan et al., Arthroscopy (2024) — doi:10.1016/j.arthro.2024.03.018 Wang et al., Arthritis & Rheumatology (2014) — doi:10.1002/art.38576 Request the full set →
Portable Diagnostic Imaging

Evidence on point-of-care imaging

Data on portable imaging accuracy and workflow impact in outpatient and mobile surgical settings.

Request the literature →
Have a question?

Ask us directly

If you're looking for a specific study or data point ahead of a VAC submission, reach out and we'll get it to you.

Contact Us